Ignite Creation Date:
2025-12-26 @ 11:47 AM
Ignite Modification Date:
2026-03-05 @ 2:31 PM
Study NCT ID:
NCT01119716
Status:
COMPLETED
Last Update Posted:
2024-06-12
First Post:
2010-05-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Study Overview
Official Title:
International Registry on Cardioversion of Atrial Fibrillation
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RHYTHM-AF
Brief Summary:
This study will create a prospective registry of consecutive patients with Atrial Fibrillation (Afib) considered for cardioversion treatment to document up-to-date practice of in-hospital treatment, with a focus on the characterization of type of Afib, as well as on treatments applied (drugs, devices, interventions and their combinations), and associated complications within 60 days after enrollment.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2010_025 | None | None | View |